The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Open accessAbstract
ngiotensin-converting enzyme (ACE) inhibitors are commonly used drugs in the management of a variety of cardiovascular diseases.They are effective antihypertensive agents.1-3Early studies have demonstrated reductions in mortality and symptoms of heart failure in patients with severe congestive heart failure.4More recently, clinical trials have demon- strated reductions in mortality and in hospitalizations for heart failure when these agents were used in pa- tients with moderate left ventricular dysfunction, with and without overt heart failure, further expanding the clinical value of these drugs in the management of patients with cardiac diseases.These benefits have been observed consistently in several trials,5-7 in patients with ischemic and nonischemic causes for the left ventricular dysfunction and with or without recent myocardial infarction.The reductions in progressive heart failure and mortality in these patients are at least partly related to a beneficial effect on left ventricular remodeling and reductions in left ventricular enlargement.8-10Other potential beneficial effects of these agents, such as regression of left ventricular hypertrophy and retarda- tion of the rate of loss of renal function in patients with diabetic nephropathy, have been brought into focus by recent trials and also by experimental studies that explore their mechanisms of action.A new and important potential role for ACE inhibi- tors is suggested by the recent trials in patients with low ejection fraction, which documented a significant reduc- tion in major ischemic events such as myocardial infarction, unstable angina, and the need for coronary revascularization procedures.In addition, parallel epi- demiological, genetic, and experimental studies suggest that the renin-angiotensin-aldosterone system may have a role in the development of coronary artery disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Self-citationEffect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Brunner, H. R., Laragh, J. H., Baer, L., Newton, M. A., Goodwin, F. T., Krakoff, L. R., Bard, R. H., & Bühler, F. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197203022860901 · Cited by 1,093
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Swedberg, K., Held, P., Kjekshus, J., Rasmussen, K., Rydén, L., & Wedel, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271002 · Cited by 964
Pollare, T., Lithell, H., & Berne, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211305 · Cited by 856
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., & Finn, P. (1985) · Circulation · doi:10.1161/01.cir.72.2.406 · Cited by 718
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Self-citationKANNEL, W. B., GORDON, T., CASTELLI, W. P., & MARGOLIS, J. R. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-813 · Cited by 636
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy
McLenachan, J. M., Henderson, E., Morris, K. I., & Dargie, H. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171302 · Cited by 579
YUSUF, S., COLLINS, R., PETO, R., FURBERG, C., STAMPFER, M. J., GOLDHABER, S. Z., & HENNEKENS, C. H. (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061905 · Cited by 568
Self-citation(1992) · Circulation · doi:10.1161/01.cir.86.1.100 · Cited by 539
Vasodilation to acetylcholine in primary and secondary forms of human hypertension.
Taddei, S., Virdis, A., Mattei, P., & Salvetti, A. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.929 · Cited by 535
TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
Sharpe, N., Smith, H., Murphy, J., & Hannan, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90347-9 · Cited by 481
Raynolds, M. V., Bristow, M. R., Bush, E. W., Abraham, W. T., Lowes, B. D., Zisman, L. S., Taft, C. S., & Perryman, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92061-w · Cited by 413
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
MARIAN, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)92064-z · Cited by 409
Endothelium-derived contracting factors.
Lüscher, T. F., Boulanger, C. M., Dohi, Y., & Yang, Z. H. (1992) · Hypertension · doi:10.1161/01.hyp.19.2.117 · Cited by 401
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Molecular biology of the renin-angiotensin system.
Griendling, K. K., Murphy, T. J., & Alexander, R. W. (1993) · Circulation · doi:10.1161/01.cir.87.6.1816 · Cited by 400
Angiotensin II Induces c-fos mRNA in Aortic Smooth Muscle
Taubman, M. B., Berk, B. C., Izumo, S., Tsuda, T., Alexander, R. W., & Nadal-Ginard, B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31290-5 · Cited by 396
Evidence for a Central Mechanism in Angiotensin Induced Hypertension.
Bickerton, R. K., & Buckley, J. P. (1961) · Experimental Biology and Medicine · doi:10.3181/00379727-106-26492 · Cited by 387
Turlapaty, P. D. M. V., & Altura, B. M. (1980) · Science · doi:10.1126/science.7361117 · Cited by 384
Sudden death: Lessons from subsets in population studies
Kannel, W. B., & Schatzkin, A. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80545-3 · Cited by 381
Wiemer, G., Schölkens, B. A., Becker, R. H., & Busse, R. (1991) · Hypertension · doi:10.1161/01.hyp.18.4.558 · Cited by 349
Linz, W., Schölkens, B. A., & Ganten, D. (1989) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968909038172 · Cited by 336
Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.
Ertl, G., Kloner, R. A., Alexander, R. W., & Braunwald, E. (1982) · Circulation · doi:10.1161/01.cir.65.1.40 · Cited by 310
Sharpe, N., Smith, H., Murphy, J., Greaves, S., Hart, H., & Gamble, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90202-z · Cited by 308
Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro
Campbell-Boswell, M., & Robertson, A. L. (1981) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(81)90066-6 · Cited by 305
Tiret, L., Nicaud, V., Kee, F., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Amouyel, P., Poirier, O., Lecerf, L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91075-w · Cited by 254
Interaction Between Sympathetic and Renin-angiotensin System
Zimmerman, B. G., Sybertz, E. J., & Wong, P. C. (1984) · Journal of Hypertension · doi:10.1097/00004872-198412000-00002 · Cited by 244
Dunn, F. G., Oigman, W., Ventura, H. O., Messerli, F. H., Kobrin, I., & Frohlich, E. D. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90692-1 · Cited by 236
Clozel, M., Kuhn, H., & Hefti, F. (1990) · Hypertension · doi:10.1161/01.hyp.16.5.532 · Cited by 230
Benedict, C. R., Johnstone, D. E., Weiner, D. H., Bourassa, M. G., Bittner, V., Kay, R., Kirlin, P., Greenberg, B., Kohn, R. M., Nicklas, J. M., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90385-9 · Cited by 225
Self-citationRegression of left ventricular hypertrophy from systemic hypertension by enalapril
Nakashima, Y., Fouad, F. M., & Tarazi, R. C. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90634-9 · Cited by 208
Beneficial Effects of the Converting Enzyme Inhibitor, Ramipril, in Ischemic Rat Hearts
Linz, W., Schölkens, B. A., & Han, Y.-F. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198600101-00017 · Cited by 205
Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.
Naftilan, A. J., Pratt, R. E., Eldridge, C. S., Lin, H. L., & Dzau, V. J. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.706 · Cited by 202
van Gilst, W. H., Graeff, D. P., Wesseling, H., & de Langen, C. D. J. (1986) · PubMed · Cited by 201
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation
HUGHES, J., & ROTH, R. H. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb08025.x · Cited by 197
Effects of Captopril on Atherosclerosis in Cynomolgus Monkeys
Aberg, G., & Ferrer, P. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000005-00010 · Cited by 196
Influence of the angiotensin system on endothelial and smooth muscle cell migration.
Bell, L. B., & Madri, J. A. (1990) · Europe PMC (PubMed Central) · Cited by 181
The Effects of Antihypertensive Agents on Serum Lipids and Lipoproteins
Lardinois, C. K. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.6.1280 · Cited by 175
Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats
Paquet, J.-L., Baudouin-Legros, M., Brunelle, G., & Meyer, P. (1990) · Journal of Hypertension · doi:10.1097/00004872-199006000-00010 · Cited by 175
Antihypertensive Treatment and Serum Lipoproteins
Weidmann, P., Uehlinger, D. E., & Gerber, A. (1985) · Journal of Hypertension · doi:10.1097/00004872-198508000-00001 · Cited by 174
Clozel, M., Kuhn, H., Hefti, F., & Baumgartner, H. R. (1991) · Hypertension · doi:10.1161/01.hyp.18.2.132 · Cited by 167
Cardiac renin-angiotensin system
Dzau, V. J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90201-x · Cited by 148
Kawahara, Y., Sunako, M., Tsuda, T., Fukuzaki, H., Fukumoto, Y., & Takai, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90485-8 · Cited by 144
Induction of the Proto-Oncogene c- jun by Angiotensin II
Naftilan, A. J., Gilliland, G., Eldridge, C. S., & Kraft, A. S. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5536 · Cited by 142
Direct myocardial effects of angiotensin II
Dempsey, P., McCallum, Z., Kent, K., & Cooper, T. (1971) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1971.220.2.477 · Cited by 128
Mak, I. T., Freedman, A. M., Dickens, B. F., & Weglicki, W. B. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90250-o · Cited by 121
Magnesium deficiency and sudden death
Eisenberg, M. J. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90633-7 · Cited by 117
Powell, J. S., Müller, R., Rouge, M., Kühn, H., Hefti, F., & Baumgartner, H. R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199016004-00010 · Cited by 112
The Epidemiology of Plasma Renin
Meade, T. W., Imeson, J., Gordon, D., & Peart, W. S. (1983) · Clinical Science · doi:10.1042/cs0640273 · Cited by 103
Plasma Renin Activity and Ischemic Heart Disease
Meade, T. W., Cooper, J. A., & Peart, W. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308263290905 · Cited by 102
Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet
Becker, R. H. A., Wiemer, G., & Linz, W. (1991) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199100182-00023 · Cited by 89
Liang, C., Gavras, H. P., Black, J., Sherman, L. G., & Hood, W. B. (1982) · Circulation · doi:10.1161/01.cir.66.6.1249 · Cited by 77
Bauwens, F. R., Duprez, D. A., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90410-m · Cited by 70
Ré, R. N. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90772-4 · Cited by 70
Huber, K. C., Schwartz, R. S., Edwards, W. D., Camrud, A. R., Bailey, K. R., Jorgenson, M. A., & Holmes, D. R. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90160-b · Cited by 64
Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction.
Søgaard, P., Gøtzsche, C.-O., Ravkilde, J., & Thygesen, K. A. (1993) · Circulation · doi:10.1161/01.cir.87.4.1093 · Cited by 59
Local Inhibition of Bradykinin Degradation in Ischemic Hearts
Linz, W., Martorana, P. A., & Schölkens, B. A. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000156-00018 · Cited by 54
Local Inhibition of Bradykinin Degradation in Ischemic Hearts
Linz, W., Martorana, P. A., & Schölkens, B. A. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199015061-00018 · Cited by 54
Farber, H. W., Rounds, S., & Danilov, S. M. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_b.100 · Cited by 51
Cardioprotective Effects of Enalapril in Acute Myocardial Ischemia
Lefer, A. M., & Peck, R. C. (2008) · Pharmacology · doi:10.1159/000137993 · Cited by 50
Przyklenk, K., & Kloner, R. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03592.x · Cited by 48
Levy, B. I., Michel, J., Salzmann, J. L., et al. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90946-a · Cited by 45
Induction of Thrombospondin Expression in Vascular Smooth Muscle Cells by Angiotensin II
Scott‐Burden, T., Resink, T. J., Hahn, A. W. A., & Bühler, F. R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000167-00007 · Cited by 45
Ziogas, J., Story, D., & Rand, M. J. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90672-1 · Cited by 45
Zimmerman, B. G. (1967) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27756-4 · Cited by 44
Kannel, W. B., Gordon, T., Castelli, W. P., & Margolis, J. R. (1971) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197101000-00029 · Cited by 44
Powers, E. R., Bannerman, K. S., Stone, J., Reison, D. S., Escala, E., Alan, K., Weiss, M. B., Sciacca, R. R., & Cannon, P. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90052-7 · Cited by 41
Texter, M. J., Lees, R. S., Pitt, B., Dinsmore, R. E., & Uprichard, A. C. G. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878518 · Cited by 39
Self-citationChobanian, A. V. (2009) · Clinical Cardiology · doi:10.1002/clc.4960131409 · Cited by 37
Angiotensin II and sympathetic activity in patients with congestive heart failure
Goldsmith, S. R., Hasking, G. J., & Miller, E. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90232-p · Cited by 36
The metabolic syndrome and signal transduction of gene expression
Rupp, H. (1991) · Steinkopff eBooks · doi:10.1007/978-3-662-30769-4_7 · Cited by 29
Plasma Renin Activity and Ischemic Heart Disease
Alderman, M. H., Sealey, J. E., & Laragh, J. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300716 · Cited by 24
Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty
Bilazarian, S., Currier, J. W., Haudenschild, C. C., Heyman, D., Powell, J. R., Ryan, T. J., & Faxon, D. P. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)92040-s · Cited by 20
Angiotensin converting enzyme inhibitors and the cardiovascular system.
Dzau, V. J. (1992) · PubMed · Cited by 15
Cited by
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Metadata
- Authors
- Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B.
- Venue
- Circulation
- Published
- 1994-10
- Volume
- 90
- Issue
- 4
- Pages
- 2056-2069
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2064099037
- Cited by
- 503
- References
- 92
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.